These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36678897)
1. In Vitro-In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action. Rath S; Kanfer I Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678897 [TBL] [Abstract][Full Text] [Related]
2. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams. Nallagundla S; Patnala S; Kanfer I AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615 [TBL] [Abstract][Full Text] [Related]
3. Application of a dermatopharmacokinetic (DPK) method for bioequivalence assessment of topical metronidazole creams. Rath S; Ramanah A; Bon C; Kanfer I J Pharm Pharm Sci; 2020; 23():437-450. PubMed ID: 33156995 [TBL] [Abstract][Full Text] [Related]
4. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream. Saeheng S; Nosoongnoen W; Varothai S; Sathirakul K Drug Dev Ind Pharm; 2013 Sep; 39(9):1372-7. PubMed ID: 23057672 [TBL] [Abstract][Full Text] [Related]
5. A Validated IVRT Method to Assess Topical Creams Containing Metronidazole Using a Novel Approach. Rath S; Kanfer I Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028557 [TBL] [Abstract][Full Text] [Related]
6. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug. Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506 [TBL] [Abstract][Full Text] [Related]
7. A comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams. Wellington H; Rath S; Kanfer I Eur J Pharm Sci; 2024 Jan; 192():106649. PubMed ID: 37992910 [TBL] [Abstract][Full Text] [Related]
8. Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling. Pensado A; Hattam L; White KAJ; McGrogan A; Bunge AL; Guy RH; Delgado-Charro MB Mol Pharm; 2021 Jul; 18(7):2714-2723. PubMed ID: 34124907 [TBL] [Abstract][Full Text] [Related]
9. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Lake OA; Olling M; Barends DM Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323 [TBL] [Abstract][Full Text] [Related]
10. Development of optimal in vitro release and permeation testing method for rectal suppositories. Srivatsa Palakurthi S; Bharat Charbe N; Recalde Phillips SY; Alge DL; Lu D; Palakurthi S Int J Pharm; 2023 Jun; 640():123042. PubMed ID: 37178789 [TBL] [Abstract][Full Text] [Related]
18. Progress in methodologies for evaluating bioequivalence of topical formulations. Shah VP Am J Clin Dermatol; 2001; 2(5):275-80. PubMed ID: 11721645 [TBL] [Abstract][Full Text] [Related]
19. Characteristic differences in barrier and hygroscopic properties between normal and cosmetic dry skin. I. Enhanced barrier analysis with sequential tape-stripping. Lu N; Chandar P; Tempesta D; Vincent C; Bajor J; McGuiness H Int J Cosmet Sci; 2014 Apr; 36(2):167-74. PubMed ID: 24397786 [TBL] [Abstract][Full Text] [Related]
20. A New Level A Type IVIVC for the Rational Design of Clinical Trials Toward Regulatory Approval of Generic Polymeric Long-Acting Injectables. Somayaji MR; Das D; Przekwas A Clin Pharmacokinet; 2016 Oct; 55(10):1179-1190. PubMed ID: 27349905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]